减重手术与肥胖成人皮肤癌发病风险的关联:非随机对照试验
瑞典肥胖受试者(SOS)研究纳入2007例接受减重手术的肥胖患者和2040例同期匹配的常规治疗对照,随访中位18.1年。
要点
- 减重手术与肥胖成人黑色素瘤风险降低相关,校正亚风险比0.43。
- 减重手术与总体皮肤癌风险降低相关,校正亚风险比0.59。
- 皮肤癌风险降低与基线BMI、体重及代谢指标无关。
核心结论
- 肥胖个体接受减重手术与皮肤癌(包括黑色素瘤)风险降低相关。
研究设计与样本
- 非随机对照试验(瑞典肥胖受试者SOS研究),在瑞典25个外科部门和480个初级保健中心进行。
- 纳入2007例接受减重手术的肥胖患者和2040例同期匹配的常规肥胖治疗对照,1987年9月1日至2001年1月31日入组。
- 手术组接受胃旁路术(n=266)、束带术(n=376)或垂直束带胃成形术(n=1365)。
- 共4047例参与者,平均年龄47.9岁(SD 6.1),女性2867例(70.8%),4042例有癌症事件信息。
主要发现
- 皮肤癌风险降低与基线BMI、体重、胰岛素、血糖、血脂、肌酐水平、糖尿病、血压、酒精摄入或吸烟无关。
临床怎么用
- 对肥胖成人,减重手术可能降低皮肤癌(包括黑色素瘤)风险,可作为代谢减重决策的额外获益参考。
局限性
- 为非随机对照试验,可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Obesity is a cancer risk factor, and bariatric surgery in patients with obesity is associated with reduced cancer risk. However, evidence of an association among obesity, bariatric surgery, and skin cancer, including melanoma, is limited. OBJECTIVE: To investigate the association of bariatric surgery with skin cancer (squamous cell carcinoma and melanoma) and melanoma incidence. DESIGN, SETTING, AND PARTICIPANTS: This nonrandomized controlled trial, the Swedish Obese Subjects (SOS) study, is ongoing at 25 surgical departments and 480 primary health care centers in Sweden and was designed to examine outcomes after bariatric surgery. The study included 2007 patients with obesity who underwent bariatric surgery and 2040 contemporaneously matched controls who received conventional obesity treatment. Patients were enrolled between September 1, 1987, and January 31, 2001. Data analysis was performed from June 29, 2018, to November 22, 2018. INTERVENTIONS: Patients in the surgery group underwent gastric bypass (n = 266), banding (n = 376), or vertical banded gastroplasty (n = 1365). The control group (n = 2040) received the customary treatment for obesity at their primary health care centers. MAIN OUTCOMES AND MEASURES: The SOS study was cross-linked to the Swedish National Cancer Registry, the Cause of Death Registry, and the Registry of the Total Population for data on cancer incidence, death, and emigration. RESULTS: The study included 4047 participants (mean [SD] age, 47.9 [6.1] years; 2867 [70.8%] female). Information on cancer events was available for 4042 patients. The study found that bariatric surgery was associated with a markedly reduced risk of melanoma (adjusted subhazard ratio, 0.43; 95% CI, 0.21-0.87; P = .02; median follow-up, 18.1 years) and risk of skin cancer in general (adjusted subhazard ratio, 0.59; 95% CI, 0.35-0.99; P = .047). The skin cancer risk reduction was not associated with baseline body mass index or weight; insulin, glucose, lipid, and creatinine levels; diabetes; blood pressure; alcohol intake; or smoking. CONCLUSIONS AND RELEVANCE: The results of this study suggest that bariatric surgery in individuals with obesity is associated with a reduced risk of skin cancer, including melanoma. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01479452.
引用
- Taube M, Peltonen M, Sjöholm K, et al. Association of Bariatric Surgery With Skin Cancer Incidence in Adults With Obesity: A Nonrandomized Controlled Trial. JAMA Dermatol. 2020. PMID: 31664428. doi:10.1001/jamadermatol.2019.3240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。